Roughly two out of every three people worldwide have oral herpes. The World Health Organization estimates that 3.8 billion people under age 50, or 64% of the global population in that age range, carry herpes simplex virus type 1 (HSV-1), the virus responsible for the vast majority of oral herpes infections. In the United States, the number is lower but still substantial: about 48% of people aged 14 to 49 test positive for HSV-1 antibodies.
Global Prevalence by Region
Oral herpes rates vary dramatically depending on where you live. Africa has the highest prevalence, with roughly 88% of both men and women carrying HSV-1. Southeast Asia and the Western Pacific also have very high infection numbers. At the other end of the spectrum, the Americas have the lowest regional prevalence: about 38% of women and 32% of men. These differences largely reflect how early in life people are exposed to the virus, since in many parts of the world, children acquire HSV-1 from family members through normal household contact well before adulthood.
Rates in the United States
The most recent national data, drawn from the 2015–2016 National Health and Nutrition Examination Survey, puts HSV-1 prevalence among Americans aged 14 to 49 at 47.8%. That means just under half of people in this age range have been infected at some point, whether or not they’ve ever had a visible cold sore.
This number has actually been declining over the past few decades. Better hygiene and less crowded living conditions mean fewer children are picking up the virus early in life. While that sounds like straightforward good news, it has a flip side: people who don’t encounter HSV-1 as children lack the partial immune protection it provides, which may leave them more vulnerable to acquiring it as a genital infection through oral sex later in life.
How Age Affects Your Likelihood
Age is the single strongest predictor of whether someone carries HSV-1. Among children in the general U.S. population, pooled estimates put seroprevalence at about 38%. Among adults, that figure climbs to roughly 64%. Age alone explains over 40% of the variation in infection rates across studies, which makes sense: the longer you’ve been alive, the more opportunities you’ve had for exposure. By the time people reach their 60s and 70s, the majority have been infected.
Most People Never Get Cold Sores
One of the most important things to understand about oral herpes is that most people who carry the virus don’t know it. The majority of HSV-1 infections produce no symptoms at all, or symptoms so mild they’re mistaken for chapped lips or a minor skin irritation. Only a fraction of carriers ever develop the classic cold sore blisters around the mouth. This is why the true prevalence is so much higher than most people assume. If you’ve never had a cold sore, that doesn’t mean you’re not carrying the virus.
Even without visible sores, the virus can occasionally reactivate and shed from the skin’s surface. This asymptomatic shedding is one of the main reasons oral herpes is so widespread. People transmit it through kissing, sharing utensils, or other close contact without realizing they’re infectious.
HSV-1 vs. HSV-2 in Oral Infections
While HSV-1 causes the overwhelming majority of oral herpes, HSV-2 (the type more commonly associated with genital herpes) can occasionally infect the mouth as well. It’s far less common, though. In people carrying antibodies to both virus types, oral shedding of HSV-2 occurs at a rate of about 0.06%, compared to 1% for HSV-1. In practical terms, if you have oral herpes, it’s almost certainly HSV-1.
Why the Real Numbers May Be Higher
Even the estimates above likely undercount true infections. Blood tests for herpes detect antibodies rather than the virus itself, and these antibodies can take up to 16 weeks to develop after exposure. Someone tested too soon after infection will get a negative result. The tests also have meaningful limitations in accuracy compared to screening for other infections like chlamydia or gonorrhea, with a higher chance of both false positives and false negatives. Combined with the fact that most carriers have no symptoms and therefore never seek testing, the commonly cited figures represent a floor, not a ceiling.
Routine screening for HSV-1 isn’t recommended in most clinical settings precisely because the virus is so common and the available blood tests aren’t precise enough to justify widespread use. The most reliable way to confirm an active infection is testing a sample directly from a sore during an outbreak, but that only works for the minority of people who develop visible symptoms.